Exodus Point Capital Management, LP Enochian Biosciences Inc Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	N/A	58,779 New	58,779 $156,000
Q2 2022 Aug 19, 2022	SELL	$1.93 - $8.73 $98,675 - $446,338	-51,127 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.42 - $9.0 $9,171 - $18,675	-2,075 Reduced 3.9%	51,127 $422,000
Q4 2021 Feb 11, 2022	BUY	$6.71 - $12.55 $356,985 - $667,685	53,202 New	53,202 $388,000
Q2 2019 Aug 14, 2019	SELL	$4.5 - $6.99 $147,186 - $228,628	-32,708 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.82 - $9.25 $190,360 - $302,549	32,708 New	32,708 $227,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.